Medanta – The Medicity, a multi-speciality institute located in National Capital Region, has introduced the ‘Scar Free Breast Biopsy’ treatment in India. The treatment ensures 99% scar free detection and removal of benign lumps. This new technology saves women from breast amputation and other causalities related to cancer, as early diagnosis of the disease is now possible.
TheWorld Health Organization (WHO) has predicted that by 2020, one in eight urban Indian women will develop breast cancer in her lifetime. Presently, one in four female cancer cases are breast cancers*. The disease is prevalent in India, claiming one in 28 urban women as victims.
About MRI – Guided Vacuum assisted Breast Biopsy (VABB)
Scar Free Breast Biopsy’ is also known as Guided Vacuum assisted Breast Biopsy (VABB). The biggest positive for the women undergoing this surgery is that it will not leave any ‘scar’ on the breast post the procedure. It offers very early diagnosis of really small abnormalities (as small as 1-2mm) which are not visualized on ultrasound or mammography and are only visible on MRI. Adequate samples of the lesions are collected, with its unique suction technology in a single prick of the needle that enhances the accuracy of the procedure.
Commenting on the announcement, Dr. Naresh Trehan, Founder and Chairman, Medanta - The Medicity said, “We are proud to bring yet another ground-breaking technology to India that relieves 49% of our population from the fear of after-effects of the breast cancer detection process. Women in India now have access to the international grade technology that delivers scar free detection and treatment of breast cancer.”
Dr. Jyoti Arora, who is a leading breast interventional radiologist in India and Sr Consultant Radiologist at Medanta the Medicity is a frequent user of this technology and she says, “This technology currently is the last stop for breast biopsy and is recommended specifically for difficult lesions when we can’t target them under other modalities like ultrasound and mammography. VABB technology increases the efficiency, accuracy and eases of targeting these breast lesions and is the standard of care in the Western world.”
“This technology is now being used to remove small benign (non-cancerous) breast lumps after careful patient selection. The whole procedure can be done under local anesthetic as an OPD procedure. The major advantages are: It is scar free, with quick healing time and no risk of general anesthesia,” Dr. Arora added.
Be notified when new press releases are added.
We love to hear about our doctors, facilities
and your treatment at Medanta.
The User agrees and acknowledges that the User has read, understood and accepts the terms and conditions contained in the brochure provided with the Device (“Device”) with respect to its usage, operations, return / replacement and warranty policy.
The User hereby agrees and acknowledges that the Device (hardware and software) used in the provision
of services by Medanta is being provided on “as is” and “as available” basis through Alivecor India Private
Limited. Neither does Medanta endorse or promote the Device in any manner nor will Medanta be liable
for any claims, representations or warranties, whether express or implied as to the safety, reliability,
durability and performance of the device.
The services once availed cannot be cancelled except in cases where the User requests to cancel the service on the day of purchase in which case, full amount of service fees shall be refunded to the User provided that the Device has not been unboxed.
Before the expiry of service duration, the User can extend the services by availing various program options. For the said purposes, the User can call our helpline number +91 124 4141414 or visit www.medanta.org. The extended program availed by the User shall be activated automatically on expiry of existing program of services.
In cases where the User has opted for availing the Services through rented Device, a refundable deposit amount of ₹ 5,000 (“Deposit Amount”) shall be applicable and paid by the User. The refund of Deposit Amount shall be subject to return of the Device in working and undamaged condition. Refund of Deposit Amount shall be made through the same mode of payment as that of purchase in cases where the User personally visits the Medanta for returning the Device. If the User opts to return the Device through post, Deposit Amount shall be refunded electronically thorough NEFT or Bank transfer by Medanta within seven (7) working days of receipt of the Device and receipt of scanned image/copy of the ‘Cancelled Cheque’ of the User’s bank account.
Upon expiry of the services (either in terms of number of ECG or duration of the program) availed by the
User, the Device has to be returned within ten (10) days failing which the Deposit Amount shall be
Please note that the ECG pack or Refundable Device deposit are non-transferable from one patient to another.